During the three and six months ended June 30, 2022 and 2021, NMM earned approximately $4.8 million and $4.2 million, respectively, and $11.1 million and $8.7 million, respectively, in management fees from LMA, which is accounted for under the equity method based on the 25% equity ownership interest held by APC in LMA’s IPA line of business (see Note 5 — “Investments in Other Entities — Equity Method”).

APC and PMIOC have an Ancillary Service Contract together whereby PMIOC provides covered services on behalf of APC to enrollees of the plans of APC. During the three and six months ended June 30, 2022 and 2021, APC paid approximately $0.7 million and $0.6 million, respectively, and $1.4 million and $1.0 million, respectively, to PMIOC for provider services, which is accounted for under the equity method based on the 40% equity ownership interest held by APC (see Note 5 — “Investments in Other Entities — Equity Method”).

During the three and six months ended June 30, 2021, APC paid $1.7 million and $3.2 million, respectively, to DMG for provider services, which is accounted for under the equity method based on the 40% equity ownership interest held by APC. In October 2021, DMG was consolidated by Apollo. As such, DMG is no longer a related party.

During the three and six months ended June 30, 2022 and 2021, APC paid approximately $0.1 million and $30,000, respectively, and $0.1 million and $51,000 to Advanced Diagnostic Surgery Center for services as a provider. Advanced Diagnostic Surgery Center shares common ownership with certain board members of APC.

During the three and six months ended June 30, 2022 and 2021, APC paid approximately $0.2 million and $0.3 million, respectively, and $0.3 million and $0.4 million, respectively, to Fulgent Genetics, Inc. for services as a provider. One of the Company’s board members is a board member of Fulgent Genetics, Inc.

During the three months ended June 30, 2022 and 2021, APC paid an aggregate of approximately $12.3 million and $8.2 million to shareholders, respectively, which included approximately $3.3 million and $2.2 million, respectively, to shareholders who are also officers of APC. During the six months ended June 30, 2022 and 2021, APC paid an aggregate of approximately $21.6 million and $15.6 million to shareholders, respectively, and $5.2 million and $3.8 million, respectively, to shareholders who are also officers of APC.

For the three and six months ended June 30, 2022 and 2021, SCHC paid approximately $0.1 million and $0.1 million, respectively, and $0.2 million and $0.2 million, respectively, to Numen, LLC (“Numen”) for an office lease. Numen is owned by a shareholder of APC.

During the three and six ended June 30, 2022 and 2021, NMM paid approximately $0.4 million and $0.4 million, respectively, and $0.7 million and $0.7 million, respectively, to One MSO for an office lease, which is accounted for under the equity method based on 50% equity ownership interest held by APC (see Note 5 — “Investments in Other Entities — Equity Method”).

During the three and six months ended June 30, 2022 and 2021, APC paid approximately $3.7 million and $3.6 million, respectively, and $7.3 million and to $7.0 million, respectively, to Arroyo Vista Family Health Center (“Arroyo Vista”) for services as a provider. Arroyo Vista’s chief executive officer is a member of the Company’s board of directors.

The Company has agreements with Health Source MSO Inc., a California corporation (“HSMSO”), Aurion Corporation (“Aurion”), and AHMC for services provided to the Company. One of the Company’s board members is an officer of AHMC, HSMSO, and Aurion. Aurion is also partially owned by one of the Company’s board members. The following table sets forth fees incurred and income received related to AHMC, HSMSO, and Aurion (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2022		2021		2022		2021
AHMC – Risk pool, capitation, claims payment	$	14,419	$	12,696	$	25,785	$	25,793
HSMSO – Management fees, net	(649)		(31)		(728)		(108)
Aurion – Management fees	(75)		(77)		(150)		(152)

Receipts, net	$	13,695	$	12,588	$	24,907	$	25,533

The Company and AHMC have a risk-sharing agreement with certain AHMC hospitals to share the surplus and deficits of each of the hospital pools. During the three and six months ended June 30, 2022 and 2021, the Company has recognized risk pool revenue under this agreement of $13.3 million and $14.2 million, and $25.3 million and $31.2 million, respectfully, of which $76.0 million and $58.4 million remained outstanding as of June 30, 2022 and December 31, 2021, respectively.

During the three and six months ended June 30, 2022, APC paid $9.3 million to purchase Apollo’s stock from a board member.

In addition, affiliates wholly owned by the Company’s officers, including Dr. Thomas Lam, ApolloMed’s Co-CEO and President, are reported in the accompanying consolidated statements of income on a consolidated basis, together with the Company’s subsidiaries, and therefore, the Company does not separately disclose transactions between such affiliates and the Company’s subsidiaries as related-party transactions.

For equity method investments and loans receivable from related parties, see Note 5 — “Investment in Other Entities - Equity Method” and Note 6 — “Loan Receivable and Loan Receivable - Related Parties”, respectively.